Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Reuss

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Neuro-Oncology|December 20, 2018
Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRIAlex Förster, Stefanie Brehmer, Marcel Seiz-Rosenhagen, et al.
Journal of Cancer Research and Clinical Oncology|January 6, 2019
High frequency of H3 K27M mutations in adult midline gliomasAzadeh Ebrahimi, Marco Skardelly, Martin U Schuhmann, et al.
Cancers|May 13, 2023
Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical ScorePhilip Dao Trong, Samuel Kilian, Jessica Jesser, et al.
International Journal of Molecular Sciences|October 24, 2020
Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant GliomaAnastasia Makarevic, Carmen Rapp, Steffen Dettling, et al.
Journal of Neuro-Oncology|November 19, 2009
Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft modelMaria Demestre, Jan Herzberg, Nikola Holtkamp, et al.
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Journal of Neuropathology and Experimental Neurology|February 15, 2018
Diffuse Astrocytoma, IDH-Wildtype: A Dissolving DiagnosisMartin Hasselblatt, Mohammed Jaber, David Reuss, et al.
Neuro-Oncology|November 12, 2024
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant gliomaFranziska M Ippen, Thomas Hielscher, Dennis Friedel, et al.
Radiation Oncology (London, England)|January 25, 2022
Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysisVivien N Sommerlath, Daniel Buergy, Nima Etminan, et al.
Plos One|November 10, 2012
Impaired Pten expression in human malignant peripheral nerve sheath tumoursMaren Bradtmöller, Christian Hartmann, Jan Zietsch, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Neuro-Oncology|December 20, 2018
Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRIAlex Förster, Stefanie Brehmer, Marcel Seiz-Rosenhagen, et al.
Journal of Cancer Research and Clinical Oncology|January 6, 2019
High frequency of H3 K27M mutations in adult midline gliomasAzadeh Ebrahimi, Marco Skardelly, Martin U Schuhmann, et al.
Cancers|May 13, 2023
Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical ScorePhilip Dao Trong, Samuel Kilian, Jessica Jesser, et al.
International Journal of Molecular Sciences|October 24, 2020
Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant GliomaAnastasia Makarevic, Carmen Rapp, Steffen Dettling, et al.
Journal of Neuro-Oncology|November 19, 2009
Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft modelMaria Demestre, Jan Herzberg, Nikola Holtkamp, et al.
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Journal of Neuropathology and Experimental Neurology|February 15, 2018
Diffuse Astrocytoma, IDH-Wildtype: A Dissolving DiagnosisMartin Hasselblatt, Mohammed Jaber, David Reuss, et al.
Neuro-Oncology|November 12, 2024
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant gliomaFranziska M Ippen, Thomas Hielscher, Dennis Friedel, et al.
Radiation Oncology (London, England)|January 25, 2022
Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysisVivien N Sommerlath, Daniel Buergy, Nima Etminan, et al.
Plos One|November 10, 2012
Impaired Pten expression in human malignant peripheral nerve sheath tumoursMaren Bradtmöller, Christian Hartmann, Jan Zietsch, et al.
Pageof 7